Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals was among the top gainers within the Biotech Industry Wednesday. Shares of the company gained 11 percent on more than double the average daily volume to close at $4.95 a share. Piper Jaffray analyst Charles Duncan has recently upgraded the company’s rating to “overweight” from “neutral”.
Going forward ... (see research report)
Subscribe to News Feeds